Header Logo

Connection

Hajime Senjo to Lymphoma, Non-Hodgkin

Back to Details
This is a "connection" page, showing publications Hajime Senjo has written about Lymphoma, Non-Hodgkin.
Hajime Senjo
Connection Strength
0.174
Lymphoma, Non-Hodgkin
  1. Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan. Int J Clin Oncol. 2023 Jun; 28(6):816-826.
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.